-
China’s NMPA Approves Sacituzumab Tirumotecan for Pretreated EGFR+ Advanced NSCLC
10 Mar 2025 21:28 GMT
… metastatic nonsquamous non–small cell lung cancer (NSCLC) following disease progression … every other week vs docetaxel in patients with previously … OS) vs those treated with docetaxel.
"We are very … in the field of lung cancer. The successful approval of …
-
Non-Small Cell Lung Cancer Market Set for Significant Growth Across the 7MM During the Study Period (2025-2034) Due to the Rising Novel Therapeutic Options | DelveInsight
26 Feb 2025 18:00 GMT
… diagnosing NSCLC and other lung cancers can be challenging … Teliso-V to docetaxel in patients with … small Cell Lung Cancer Pipeline Non-small Cell Lung Cancer Pipeline Insight … Cell Lung Cancer Epidemiology Forecast Non-small Cell Lung Cancer Epidemiology …
-
KRAS, EGFR, and the Future of Lung Cancer Treatment
26 Feb 2025 15:30 GMT
… developments in the field of lung cancer in 2024.
I think … trial comparing sotorasib with docetaxel, which showed between a … a marginal advantage over docetaxel in randomized trials, along … could beat docetaxel.
However, please remember that docetaxel is an …
-
The Inter-Relationships Among the Risk Factors for Pulmonary Infection and the Diagnostic Utility of Inflammatory Markers in Patients with Non-Small Cell Lung Cancer
25 Feb 2025 02:55 GMT
… lung cancer is the highest in China, and lung cancer … non-small-cell lung cancer. Clin Lung Cancer. 2021;22(2 … advanced non-small cell lung cancer treated with chemoradiotherapy. … docetaxel in patients with platinum-treated advanced non-small-cell lung cancer …
-
Metabolomic Analysis, Antiproliferative, Anti-Migratory, and Anti-Invasive Potential of Amlodipine in Lung Cancer Cells
19 Feb 2025 00:32 GMT
… lung cancer (NSCLC) forms approximately 80% of all lung cancer … treated with amlodipine.
Discussion
Lung cancer, specifically NSCLC, continues … pathway after treating lung cancer cells A549 with … channel blockers reverse docetaxel and vincristine-induced …
-
Innovent receives second fast track designation from US FDA for IBI363 in squamous non─small cell lung cancer
18 Feb 2025 03:55 GMT
… squamous non-small cell lung cancer (sqNSCLC) that has … expression. In addition to lung cancer, we have observed encouraging … lung cancer (NSCLC) accounts for more than 80% of all lung cancer … or third-line treatment, docetaxel, offers limited efficacy, with …
-
Combined Albumin Polyester Nanocarriers with Docetaxel for Effective Against Lung Cancer in Mice Model
17 Feb 2025 14:50 GMT
… lung cancer therapy lies in enhancing its concentration within lung tumor … lung cancer cells, significantly inhibit the growth of lung cancer … lung cancer treated with docetaxel in second-line or beyond. Lung Cancer … small cell lung cancer. Lung Cancer. 2023;180 …
-
Innovent Receives Second Fast Track Designation From The U.S. FDA For IBI363 (PD-1/IL-2Α-Bias Bispecific Antibody Fusion Protein) In Squamous Non-Small Cell Lung Cancer
17 Feb 2025 01:33 GMT
… squamous non-small cell lung cancer (sqNSCLC) that has … expression. In addition to lung cancer, we have observed encouraging … Non-Small Cell Lung Cancer (sqNSCLC)
Lung cancer is the most … or third-line treatment, docetaxel, offers limited efficacy, with …
-
Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer
05 Feb 2025 07:15 GMT
… plus docetaxel versus docetaxel alone (docetaxel subgroup population … TTFields therapy plus docetaxel, docetaxel alone, TTFields … therapy + docetaxel versus docetaxel alone docetaxel alone.
Discussion … docetaxel in previously treated non-small-cell lung cancer …
-
Non-Small Cell Lung Cancer Pipeline, Clinical Trials, Emerging Drugs Approvals and Companies | DelveInsight
22 Jan 2025 10:41 GMT
… Lung Cancer treatment.
• The leading Non-Small Cell Lung Cancer … deruxtecan, DS-1062a, Docetaxel, Pembrolizumab (MK-3475) … Cell Lung Cancer Clinical Trials Assessment
Non-Small-Cell Lung cancer … lung cancer.
Learn more about Non-Small Cell Lung Cancer …
About
© 1995-2025